Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

FHS
July 9, 2024
3:16 am

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes.

MEDICLIN reports solid first half of 2024 – Biotech Investments

EQS-News: MEDICLIN AG / Key word(s): Half Year Results/Half Year Report MEDICLIN reports solid first half of 2024 31.07.2024 / 13:31 CET/CEST The issuer is

August 1, 2024

Debunking Fluoride Misinfo; Mummy Gets CT Scan; Come Quit My NP Job With Me

The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. After Robert F. Kennedy Jr. announced on X that President-elect

November 15, 2024

Functional, nonepileptic seizures linked to higher death rate than expected

The death rate for patients with functional, nonepileptic seizures is higher than expected, with a rate comparable to epilepsy and severe mental illness, a Michigan

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.